Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-25 8:01 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 3,992,586 9.9% | -2,684,347 (-40.20%) | View |
| 2024-02-14 8:31 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 6,676,933 9.9% | 4,518,661 (+209.36%) | View |
| 2024-02-14 4:51 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Nantahala Capital Management LLC | 3,229,903 9.9% | 3,229,903 (New Position) | View |
| 2024-02-14 4:29 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Lincoln Park Capital Fund LLC | 1,307,049 9.676% | 369,461 (+39.41%) | View |
| 2024-02-14 3:23 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | LYTTON LAURENCE W | 3,280,178 9.99% | 1,395,105 (+74.01%) | View |
| 2024-02-07 6:58 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | HIRSCHMAN ORIN | 2,662,324 8.7% | 747,104 (+39.01%) | View |
| 2024-01-31 08:00 am Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | ADAR1 Partners LP | 1,824,063 6.21% | 1,824,063 (New Position) | View |
| 2023-12-07 5:15 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | LYTTON LAURENCE W | 1,885,073 9.99% | 1,885,073 (New Position) | View |
| 2023-12-05 06:01 am Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | HIRSCHMAN ORIN | 1,915,220 9.9% | 1,915,220 (New Position) | View |
| 2023-02-13 5:53 pm Unchanged | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 2,158,272 9.97% | 0 (Unchanged) | View |
| 2023-02-13 3:14 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | LYTTON LAURENCE W | 482,430 4.99% | -3,695,362 (-88.45%) | View |
| 2022-11-02 8:03 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 2,158,272 9.97% | -3,894,010 (-64.34%) | View |
| 2022-10-25 06:01 am Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Lincoln Park Capital Fund LLC | 937,588 9.99% | -1,376,095 (-59.48%) | View |
| 2022-02-14 7:44 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | LYTTON LAURENCE W | 4,177,792 6.6% | -566,211 (-11.94%) | View |
| 2022-02-14 1:58 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Consonance Capital Management LP | 0 0% | -4,703,435 (Position Closed) | View |
| 2022-02-10 4:02 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Sio Capital Management LLC | 0 0% | -2,331,123 (Position Closed) | View |
| 2022-01-21 3:49 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 6,052,282 9.97% | 2,845,122 (+88.71%) | View |
| 2021-07-08 1:30 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 3,207,160 6% | 3,207,160 (New Position) | View |
| 2021-02-17 3:10 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Consonance Capital Management LP | 4,703,435 9.99% | -1,355,070 (-22.37%) | View |
| 2021-02-16 5:10 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Boxer Capital LLC | 1,840,000 4% | 908,236 (+97.47%) | View |